ST PHARM News

Nov 18, 2022

ST PHARM, 2022 Sustinvest ESG Rating 'AA'

- ST Pharm ranked 4th of 99 listed pharmaceutical bio companies in Korea.

- Highest grade 'AA' for 2 years.